| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.08 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.091 | 0.09 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |